05/01/2024 6:00 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 6:09 AM | Johnson & Johnson (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 4:05 PM | Doudna Jennifer A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:05 PM | Johnson & Johnson (Issuer) Johnson Paula A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:05 PM | Johnson & Johnson (Issuer) Joly Hubert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) McClellan Mark B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) WEINBERGER MARK A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) MULCAHY ANNE M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Adamczyk Darius (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Johnson & Johnson (Issuer) West Nadja (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 4:06 PM | Beckerle Mary C (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 11:16 AM | Johnson & Johnson (Filer)
| Form 8-K/A | |
04/16/2024 6:06 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 4:05 PM | Contineum Therapeutics, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/10/2024 4:12 PM | Contineum Therapeutics, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G | |
04/05/2024 4:29 PM | Johnson & Johnson (Filed by) Shockwave Medical, Inc. (Subject)
| Form DFAN14A | |
03/27/2024 8:48 AM | Johnson & Johnson (Subject) National Legal & Policy Center (Filed by)
| Form PX14A6G | |
03/13/2024 3:28 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 3:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 6:42 AM | Johnson & Johnson (Filer)
| Form ARS | |
03/13/2024 6:35 AM | Johnson & Johnson (Filer)
| Form DEF 14A | |
03/13/2024 6:37 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/13/2024 6:39 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/06/2024 2:42 PM | CVRx, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:58 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:54 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:12 PM | Johnson & Johnson (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 4:23 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
02/15/2024 3:53 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing…
Outliving their retirement savings.
You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Click here to register for free. |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 11:55 AM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 11:35 AM | Johnson & Johnson (Subject) Taubert Jennifer L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:24 PM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:07 PM | BiomX Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:52 PM | CVRx, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:32 PM | Johnson & Johnson (Filed by) Johnson & Johnson (Filed by) Nanobiotix S.A. (Subject)
| Form SC 13G/A | |
01/30/2024 11:46 AM | Johnson & Johnson (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/29/2024 3:50 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/24/2024 11:51 AM | Johnson & Johnson (Filed by) Kenvue Inc. (Subject)
| Form SC 13G | |
01/23/2024 6:45 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:08 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 4:22 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 7:22 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
12/08/2023 3:33 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/07/2023 4:17 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:42 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 6:52 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 3:30 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:56 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/23/2023 3:48 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 6:33 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:36 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:46 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:02 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 3:53 PM | Johnson & Johnson (Reporting) Kenvue Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:04 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/23/2023 5:37 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/21/2023 5:52 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/21/2023 5:38 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/18/2023 4:11 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 3:53 PM | Johnson & Johnson (Subject)
| Form 425 | |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
08/17/2023 5:23 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/16/2023 8:22 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/16/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/15/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/14/2023 3:44 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/11/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/04/2023 3:32 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 7:03 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |